Gossamer Bio GOSS Stock
Gossamer Bio Price Chart
Gossamer Bio GOSS Financial and Trading Overview
| Gossamer Bio stock price | 10.71 USD |
| Previous Close | 10.93 USD |
| Open | 11.19 USD |
| Bid | 10.65 USD x 100 |
| Ask | 11.57 USD x 100 |
| Day's Range | 10.19 - 11.19 USD |
| 52 Week Range | 9.12 - 309.6 USD |
| Volume | 235K USD |
| Avg. Volume | 375.13K USD |
| Market Cap | 65.51M USD |
| Beta (5Y Monthly) | 2.004 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -52.8 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 82.48 USD |
GOSS Valuation Measures
| Enterprise Value | 48.49M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.6860107 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.2293388 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.91 |
| Enterprise Value/EBITDA | -0.306 |
Trading Information
Gossamer Bio Stock Price History
| Beta (5Y Monthly) | 2.004 |
| 52-Week Change | -94.68% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 309.6 USD |
| 52 Week Low | 9.12 USD |
| 50-Day Moving Average | 12.91 USD |
| 200-Day Moving Average | 65.86 USD |
GOSS Share Statistics
| Avg. Volume (3 month) | 375.13K USD |
| Avg. Daily Volume (10-Days) | 373.51K USD |
| Shares Outstanding | 6.12M |
| Float | 3.88M |
| Short Ratio | 3.28 |
| % Held by Insiders | 1.43% |
| % Held by Institutions | 84.85% |
| Shares Short | 948.62K |
| Short % of Float | 15.73% |
| Short % of Shares Outstanding | 15.50% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -235.0020% |
| Operating Margin (ttm) | -282.24% |
| Gross Margin | 100.00% |
| EBITDA Margin | -297.63% |
Management Effectiveness
| Return on Assets (ttm) | -62.39% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 53.29M USD |
| Revenue Per Share (ttm) | 16.81 USD |
| Quarterly Revenue Growth (yoy) | -19.60% |
| Gross Profit (ttm) | 53.29M USD |
| EBITDA | -158596992 USD |
| Net Income Avi to Common (ttm) | -125223000 USD |
| Diluted EPS (ttm) | -52.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 57.03M USD |
| Total Cash Per Share (mrq) | 9.33 USD |
| Total Debt (mrq) | 40.07M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.528 |
| Book Value Per Share (mrq) | -0.192 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -162626000 USD |
| Levered Free Cash Flow (ttm) | -29764624 USD |
Profile of Gossamer Bio
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 3115 Merryfield Row |
| ZIP | 92121 |
| Phone | 858 684 1300 |
| Website | https://www.gossamerbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 161 |
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
Q&A For Gossamer Bio Stock
What is a current GOSS stock price?
Gossamer Bio GOSS stock price today per share is 10.71 USD.
How to purchase Gossamer Bio stock?
You can buy GOSS shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gossamer Bio?
The stock symbol or ticker of Gossamer Bio is GOSS.
Which industry does the Gossamer Bio company belong to?
The Gossamer Bio industry is Biotechnology.
How many shares does Gossamer Bio have in circulation?
The max supply of Gossamer Bio shares is 6.12M.
What is Gossamer Bio Price to Earnings Ratio (PE Ratio)?
Gossamer Bio PE Ratio is now.
What was Gossamer Bio earnings per share over the trailing 12 months (TTM)?
Gossamer Bio EPS is -52.8 USD over the trailing 12 months.
Which sector does the Gossamer Bio company belong to?
The Gossamer Bio sector is Healthcare.
Gossamer Bio GOSS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27190.86 USD — |
+1.19
|
6.86B USD — | 27112.24 USD — | 27353.68 USD — | — - | 6.86B USD — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
13380.95 USD — |
+1.21
|
— — | 13341.63 USD — | 13459.93 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6947.64 USD — |
-0.26
|
— — | 6917.55 USD — | 6998.5 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1302.61 USD — |
-0.29
|
— — | 1298.55 USD — | 1311.62 USD — | — - | — — |
- {{ link.label }} {{link}}
